<VariationArchive VariationID="30782" VariationName="NM_012414.4(RAB3GAP2):c.499_507del (p.Phe167_Thr169del)" VariationType="Deletion" Accession="VCV000030782" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39739" VariationID="30782">
      <GeneList>
        <Gene Symbol="RAB3GAP2" FullName="RAB3 GTPase activating non-catalytic protein subunit 2" GeneID="25782" HGNC_ID="HGNC:17168" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q41</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="220148293" stop="220272453" display_start="220148293" display_stop="220272453" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="220321609" stop="220445842" display_start="220321609" display_stop="220445842" Strand="-" />
          </Location>
          <OMIM>609275</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_012414.4(RAB3GAP2):c.499_507del (p.Phe167_Thr169del)</Name>
      <CanonicalSPDI>NC_000001.11:220210803:AGTGTAGAA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q41</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="220210804" stop="220210812" display_start="220210804" display_stop="220210812" variantLength="9" positionVCF="220210803" referenceAlleleVCF="CAGTGTAGAA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="220384146" stop="220384154" display_start="220384146" display_stop="220384154" variantLength="9" positionVCF="220384145" referenceAlleleVCF="CAGTGTAGAA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.220384146_220384154del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.220384146_220384154del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.220210804_220210812del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.220210804_220210812del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015837.2" sequenceAccession="NG_015837" sequenceVersion="2" change="g.66690_66698del">
            <Expression>NG_015837.2:g.66690_66698del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012414.4" sequenceAccession="NM_012414" sequenceVersion="4" change="c.499_507del" MANESelect="true">
            <Expression>NM_012414.4:c.499_507del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_036546.2" sequenceAccession="NP_036546" sequenceVersion="2" change="p.Phe167_Thr169del">
            <Expression>NP_036546.2:p.Phe167_Thr169del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="609275.0002" DB="OMIM" />
        <XRef Type="rs" ID="1553278569" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_012414.4(RAB3GAP2):c.499_507del (p.Phe167_Thr169del) AND Warburg micro syndrome 2" Accession="RCV000023762" Version="12">
        <ClassifiedConditionList TraitSetID="7607">
          <ClassifiedCondition DB="MedGen" ID="C3280214">Warburg micro syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-01-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-01-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20967465</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7607" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16545" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MICRO SYNDROME 2</ElementValue>
                <XRef Type="MIM" ID="614225" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Warburg micro syndrome 2</ElementValue>
                <XRef ID="MONDO:0013641" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WARBM2</ElementValue>
                <XRef Type="MIM" ID="614225" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15780" />
                <XRef ID="15780" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">RAB18 deficiency is the molecular deficit underlying both Warburg micro syndrome (characterized by eye, nervous system, and endocrine abnormalities) and Martsolf syndrome (characterized by similar – but milder – findings). To date Warburg micro syndrome comprises &gt;96% of reported individuals with genetically defined RAB18 deficiency. The hallmark ophthalmologic findings are bilateral congenital cataracts, usually accompanied by microphthalmia, microcornea (diameter &lt;10), and small atonic pupils. Poor vision despite early cataract surgery likely results from progressive optic atrophy and cortical visual impairment. Individuals with Warburg micro syndrome have severe to profound intellectual disability (ID); those with Martsolf syndrome have mild to moderate ID. Some individuals with RAB18 deficiency also have epilepsy. In Warburg micro syndrome, a progressive ascending spastic paraplegia typically begins with spastic diplegia and contractures during the first year, followed by upper-limb involvement leading to spastic quadriplegia after about age five years, often eventually causing breathing difficulties. In Martsolf syndrome infantile hypotonia is followed primarily by slowly progressive lower-limb spasticity. Hypogonadism – when present – manifests in both syndromes, in males as micropenis and/or cryptorchidism and in females as hypoplastic labia minora, clitoral hypoplasia, and small introitus.</Attribute>
                <XRef ID="NBK475670" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29300443</ID>
                <ID Source="BookShelf">NBK475670</ID>
              </Citation>
              <XRef ID="2510" DB="Orphanet" />
              <XRef ID="C3280214" DB="MedGen" />
              <XRef ID="MONDO:0013641" DB="MONDO" />
              <XRef Type="MIM" ID="614225" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50309" SubmissionDate="2021-07-08" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="609275.0002_WARBURG MICRO SYNDROME 2" title="RAB3GAP2, 9-BP DEL, NT499_WARBURG MICRO SYNDROME 2" />
        <ClinVarAccession Accession="SCV000045053" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a girl from a consanguineous Turkish family with Warburg Micro syndrome-2 (WARBM2; 614225), Borck et al. (2011) identified a homozygous 9-bp in-frame deletion (499_507delTTCTACACT) in the RAB3GAP2 gene. The mutation was predicted to lead to the deletion of the amino acids phenylalanine, tyrosine, and threonine at positions 167-169 of the protein (Phe167_Thr169del). The parents were heterozygous carriers of the mutation, which was absent in 288 Turkish and 170 German control chromosomes. RT-PCR on lymphocyte RNA from the patient confirmed the homozygous 9-bp deletion at the mRNA level and detected no aberrant splicing.</Attribute>
              <Citation>
                <ID Source="PubMed">20967465</ID>
              </Citation>
              <XRef DB="OMIM" ID="614225" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAB3GAP2" />
          </GeneList>
          <Name>RAB3GAP2, 9-BP DEL, NT499</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">9-BP DEL, NT499</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609275.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">WARBURG MICRO SYNDROME 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1517777" SubmissionDate="2017-10-31" DateLastUpdated="2022-10-01" DateCreated="2018-06-04">
        <ClinVarSubmissionID localKey="NM_012414.3:c.499_507del|OMIM:614225" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000778359" DateUpdated="2022-10-01" DateCreated="2018-06-04" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20967465</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAB3GAP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_036546.2:p.Phe167_Thr169del</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609275.0002" Type="Allelic variant" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012414.3:c.499_507del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280214" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Abbrev="GeneReviews" Type="review">
          <ID Source="PubMed">29300443</ID>
          <ID Source="BookShelf">NBK475670</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1517777" TraitType="Disease" MappingType="XRef" MappingValue="C3280214" MappingRef="MedGen">
        <MedGen CUI="C3280214" Name="Warburg micro syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="50309" TraitType="Disease" MappingType="Name" MappingValue="WARBURG MICRO SYNDROME 2" MappingRef="Preferred">
        <MedGen CUI="C3280214" Name="Warburg micro syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

